About Epitel
Epitel is a company based in Salt Lake City (United States) founded in 2007 by Mark Lehmkuhle. Epitel has raised $38.5 million across 8 funding rounds from investors including HHS, OSF HealthCare and CHV. Epitel offers products and services including REMI Remote EEG Monitoring System and REMI Vigilenz AI. Epitel operates in a competitive market with competitors including Ceribell, Empatica, BioSerenity, Seer and BrainScope, among others.
- Headquarter Salt Lake City, United States
- Founders Mark Lehmkuhle
-
Sectors
TechnologyHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Epitel, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$38.5 M (USD)
in 8 rounds
-
Latest Funding Round
$26 M (USD), Series B
Jul 28, 2026
-
Investors
HHS
& 8 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Epitel
Epitel offers a comprehensive portfolio of products and services, including REMI Remote EEG Monitoring System and REMI Vigilenz AI.
Wireless system for capturing and transmitting brain activity in healthcare settings.
Analyzes EEG data to detect potential electrographic seizures accurately.
People of Epitel
Unlock access to complete
Unlock access to complete
Funding Insights of Epitel
Epitel has successfully raised a total of $38.5M across 8 strategic funding rounds. The most recent funding activity was a Series B round of $26 million completed in July 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Epitel
Epitel has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, OSF HealthCare and CHV.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Early-stage VC firm focused on life science startups
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Epitel
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Epitel
Investment portfolio details for Epitel
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Epitel
Detailed financials for Epitel
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Epitel Comparisons
Peer comparison for Epitel
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Epitel
Epitel operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ceribell, Empatica, BioSerenity, Seer and BrainScope, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Portable EEG devices for point-of-care seizure diagnosis are provided.
|
|
| Locked | Locked | Locked |
Developer of a wrist band to monitor physiological signals
|
|
| Locked | Locked | Locked |
Provider of smart healthcare solutions for sleep and EEG lab management
|
|
| Locked | Locked | Locked |
Proteomics platform developed for early cancer and neurological disease detection.
|
|
| Locked | Locked | Locked |
Developer of AI-driven EEG platform transforming brain electrical activity into insights
|
Detailed competitors of Epitel
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Epitel
Complete news archive for Epitel
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Epitel
Epitel was founded in 2007 and raised its 1st funding round 2 years after it was founded.
Epitel is headquartered in Salt Lake City, United States. It is registered at Salt Lake City, Utah, United States.
Mark Lehmkuhle is the current CEO of Epitel. They have also founded this company.
Epitel is a funded company, having raised a total of $38.5M across 8 funding rounds to date.
Epitel was founded in 2007 in Salt Lake City, United States, focusing on health technology for neurological care. A scalp-applied, adhesive-based EEG device is offered for continuous seizure monitoring, independent of time or location. The rechargeable system pairs with a mobile application via Bluetooth to detect and log seizure events. Collected data is analyzed by physicians to adjust treatments and daily routines.
Epitel's top competitors include Ceribell, Empatica and BrainScope.
Epitel offers REMI Remote EEG Monitoring System and REMI Vigilenz AI.
Epitel has 9 investors. Key investors include HHS, OSF HealthCare, CHV, Genoa Ventures, and Wavemaker 360.